Search results
Recent Insider Activity Suggests Potential Gains for Moderna Inc
Knox Daily· 19 hours agoHSBC Securities downgraded its Moderna Inc [MRNA] rating to a Reduce from a a Hold in a research note published on February 26, 2024; the price target was ...
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 6 hours agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 8 hours agoPrograms span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Where Is Moderna Standing Right ...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 day agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks· 6 days agoWall Street expects a year-over-year decline in earnings on lower revenues when Moderna (MRNA Quick QuoteMRNA - Free Report) reports results for the quarter ended ...widely-known ...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 10 hours agoIts earnings beat estimates in each of the trailing four quarters, delivering an average earnings...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 7 days agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 2 days agoFree Report) is expected to reveal quarterly loss of $3.59 per share, indicating a decline of 1989.5% compared to the year-ago period. Over the past 30 days, the consensus EPS estimate for the ...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant portion of his...
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks· 21 hours agoInvestors can't control the latter, but they can focus on a company's earnings results every quarter. This means that investors might want to take advantage of these earnings surprises. Now ...